Related Experiment Video
Updated: Feb 8, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Comprehensive analysis of PANoptosis-related molecular subtypes and prognostic model development of clear cell renal
Peng Zhou1, Zhen Xu1, Weidong Gan2
1Department of Urology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, 225300, China.
Background:
Clear cell renal cell carcinoma (ccRCC) exhibits strong heterogeneity and variable therapeutic responses. PANoptosis, an integrated form of inflammatory programmed cell death, may influence tumor immunity and prognosis, yet its role in ccRCC remains unclear.
Methods:
Multi-omics data from TCGA database were analyzed to characterize PANoptosis-related genes (PRG), define molecular and gene subtypes, and construct a prognostic PRG score using Cox and LASSO regression. Immune infiltration, drug sensitivity, and predicted immunotherapy response were evaluated. Single-cell RNA sequencing analysis was used to map PRG expression across cell populations. In vitro experiments were performed to validate RBCK1 function in ccRCC.
Results:
14 PRG showed marked CNV alterations and differential expression. Three PRG molecular subtypes displayed distinct survival outcomes and immune landscapes. A three-gene PRG score (RIPK1, PYCARD, RBCK1) independently stratified prognosis and correlated with immune infiltration, mutation burden, and therapy sensitivity. Lower scores predicted better immunotherapy response and higher drug sensitivity. Single-cell analysis revealed broad PRG expression across macrophages, epithelial cells, endothelial cells, and stem-like cells. RBCK1 was significantly upregulated in ccRCC and promoted proliferation and migration, while its knockdown inhibited tumor cell growth.
Conclusions:
We delineated the PANoptosis landscape in ccRCC and developed a robust PRG score with strong prognostic and immunological relevance. RBCK1 functions as a key oncogenic regulator and potential therapeutic target. These findings offer a valuable framework for precision risk assessment and treatment optimization in ccRCC.
Insights
Researchers identified PANoptosis-related genes (PRG) and developed a prognostic score for clear cell renal cell carcinoma (ccRCC). This score aids in assessing prognosis and predicting immunotherapy response in ccRCC patients.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Clear cell renal cell carcinoma (ccRCC) is highly heterogeneous with unpredictable treatment outcomes.
- PANoptosis, a form of inflammatory programmed cell death, is implicated in tumor immunity but its role in ccRCC is not well understood.
Purpose of the Study:
- To investigate the role of PANoptosis-related genes (PRG) in ccRCC.
- To develop a prognostic score based on PRGs for ccRCC risk stratification.
- To explore the therapeutic potential of PRGs in ccRCC.
Main Methods:
- Utilized multi-omics data from TCGA for PRG characterization and subtype definition.
- Developed a prognostic PRG score using Cox and LASSO regression.
- Analyzed immune infiltration, drug sensitivity, and immunotherapy response.
- Performed single-cell RNA sequencing and in vitro validation of RBCK1.
Main Results:
- Identified 14 PRGs with significant alterations in ccRCC.
- Defined three PRG molecular subtypes with distinct survival and immune profiles.
- Developed a three-gene PRG score (RIPK1, PYCARD, RBCK1) that predicts prognosis, immune infiltration, and therapy sensitivity.
- RBCK1 was found to be oncogenic, promoting ccRCC cell proliferation and migration.
Conclusions:
- Established the PANoptosis landscape in ccRCC and created a prognostic PRG score.
- RBCK1 is a key oncogenic driver and potential therapeutic target in ccRCC.
- The findings provide a framework for precision medicine in ccRCC treatment.
More Related Videos
Related Concept Videos
Molecular Models
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Zygotic Development And Stem Cell Formation
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Molecular Orbital Theory II

